Regression analysis in patients with thallasemia induced osteoporosis

  • Athanasios N. Tsartsalis
  • George I. Lambrou
  • Athanasia Samartzi
  • Evgenia Vlachou
  • Ioannis K. Triantafyllopoulos
  • George P. Chrousos
  • Christina Kanaka Gantenbein
  • Antonis Kattamis
Keywords: Regressions, Thalassemia Major, Osteoporosis

Abstract

Introduction: Thalassemia Major (TM) is a hereditary disease caused by defective globin synthesis. Although, it is considered a disease which is well understood both from the clinical as well as the biological aspect, it is a complex phenomenon and still remains under thorough investigation. One of the recent findings, include the fact the due to the significant increase in life expectancy, TM patients suffer from various secondary health conditions, including endocrinopathies and low bone mineral density.

Aim: The aim of the present study was to analyze biochemical factors, collected from TM patients, with the application of regression analysis in order to find probable causative relations for TM-induced osteoporosis.

Methods: Sixty-four patients with TM (32 men and 32 women) participated in a cross-sectional study design. The patients were recruited from “Aghia Sofia” Children’s Hospital and evaluated using dual-energy X-ray absorptiometry (DXA) of the lumbar spine and femoral neck and with markers of bone remodeling including receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG), C-terminal telopeptide (CTX), and sclerostin.

Results: Regression analysis, manifested significant relations in TM patients with respect to calcium, phosphorus, testosterone, luteinizing hormone, follicle stimulating hormone and DXA.

Conclusions: In TM patients, several factors appeared to be linearly correlated, which indicates that these factors play an important role in TM-induced osteoporosis.

Downloads

Download data is not yet available.

Author Biographies

Athanasios N. Tsartsalis

Naval Hospital of Athens, Department of Endocrinology Diabetes and Metabolism, Dinokratous 70, 11521, Athens Greece

George I. Lambrou

First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Athanasia Samartzi

Naval Hospital of Athens, Department of Endocrinology Diabetes and Metabolism, Dinokratous 70, 11521, Athens Greece

Evgenia Vlachou

Department of Nursery, School of Health Sciences, University of West Attica, Ag. Spydironos 28, 12243, Aigaleo, Athens, Greece

Ioannis K. Triantafyllopoulos

National and Kapodistrian University of Athens, Medical School, Laboratory for the Research of Musculoskeletal Disorders, Nikis 2, 14561, Kifissia, Athens, Greece

George P. Chrousos

First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Division of Endocrinology Diabetes and Metabolism, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Hematology/Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Christina Kanaka Gantenbein

First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Division of Endocrinology Diabetes and Metabolism, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Hematology/Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Antonis Kattamis

Hematology/Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece

Published
2020-02-27